4 patents
Utility
MCL1 Inhibitors and Uses Thereof
13 Apr 23
The present disclosure provides compounds, such as compounds of Formula I, and compositions that are MCL1 inhibitors.
Brendan M. O' Boyle, Emma L. Baker-Tripp, Corey M. Reeves, Kevin C. Yang, Tristin E. Rose, Justin A. Hilf, Brian M. Stoltz, Michael D. Bartberger, Oliver C. Loson, Martina S. McDermott, Neil A. O'Brien, Dennis Slamon
Filed: 2 Oct 20
Utility
Kras G12C Inhibitors and Uses Thereof
21 Jul 22
The invention relates to compounds of Formula I, and pharmaceutically acceptable salts thereof, and methods of making and using the same.
Justin A. Hilf, Tristin E Rose, Michael D. Bartberger, Brendan M. O'Boyle, Corey M. Reeves, Oliver C. Loson, Brian M. Stoltz, Martina S. McDermott, Neil A. O'Brien, Dennis Slamon
Filed: 20 May 20
Utility
PRMT5 Inhibitors and Uses Thereof
23 Jun 22
Brendan M. O'Boyle, Corey M. Reeves, Justin A. Hilf, Brian M. Stoltz, Michael D. Bartberger, Steven J. Wittenberger, Oliver C. Loson, Martina S. McDermott, Neil A. O'Brien, Dennis Slamon
Filed: 25 Mar 20
Utility
Erk Inhibitors and Uses Thereof
6 Jan 22
The present disclosure provides compounds and compositions that are inhibitors of ERK1, ERK2, or both, and methods of use thereof.
Corey M. Reeves, Brandan M. O'Boyle, Justin A. Hilf, Dylan Conklin, Martina S. McDermott, Neil A. O'Brien, Michael J. Palazzolo, Dennis Slamon, Steven J. Wittenberger, Oliver C. Loson, Michael D. Bartberger, Brian M. Stoltz
Filed: 15 Nov 19
- Prev
- 1
- Next
Patents are sorted by USPTO publication date, most recent first